CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-03 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | −203 | $39.20 | $8K | 453 |
| 2024-04-03 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | −453 | $40.05 | $18K | 0 |
| 2024-04-03 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | −3,112 | $38.22 | $119K | 14,909 |
| 2024-04-03 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | −2,944 | $39.19 | $115K | 11,965 |
| 2024-04-03 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | −6,965 | $40.06 | $279K | 5,000 |
| 2024-04-03 | Grant Sean CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) | −99,828 | 80,172 | ||
| 2024-03-25 | Katabi Maha Director | Sale | −340,000 | $40.50 | $13.8M | 2,793,987 |
| 2024-03-22 | Katabi Maha Director | Sale | −413,450 | $40.51 | $16.7M | 3,133,987 |
| 2024-03-21 | Katabi Maha Director | Sale | −32,756 | $43.00 | $1.4M | 3,595,690 |
| 2024-03-21 | Katabi Maha Director | Sale | −21,918 | $44.00 | $964K | 3,573,772 |
| 2024-03-21 | Katabi Maha Director | Sale | −12,617 | $45.52 | $574K | 3,561,155 |
| 2024-03-21 | Katabi Maha Director | Sale | −13,718 | $46.18 | $633K | 3,547,437 |
| 2024-01-30 | Katabi Maha Director | Purchase | +161,290 | $31.00 | $5.0M | 3,628,446 |
| 2024-01-16 | Fordyce Marshall PRESIDENT AND CEO | Grant or award | +78,750 | 335,627 | ||
| 2024-01-16 | Fordyce Marshall PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +292,500 | 292,500 | ||
| 2024-01-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Grant or award | +21,875 | 57,054 | ||
| 2024-01-16 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Grant or award · Stock Option (right to buy) | +81,250 | 81,250 | ||
| 2024-01-16 | Grant Sean CHIEF FINANCIAL OFFICER | Grant or award | +26,250 | 78,683 | ||
| 2024-01-16 | Grant Sean CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +97,500 | 97,500 | ||
| 2024-01-10 | COMMODORE CAPITAL LP 10% owner | Sale | −1,050,000 | $18.00 | $18.9M | 4,400,000 |
Page 15 of 17 · 321 trades